Preeclampsia
Preeclampsia is a pregnancy-specific multi-system disorder characterized by new-onset high blood pressure and often significant protein in the urine after 20 weeks of gestation, with potential complications including organ injury, severe hypertension, and increased risk of preterm labor. If untreated, it can lead to severe outcomes, including eclampsia, marked by seizures.
Health Outcomes
- Absence of Adverse Pregnancy Complications
- Altered Blood Pressure
- Altered Renal Profile
- Changed Maternal Plasma Fatty Acids
- Enhanced Trophoblast Invasion
- Improved Angiogenic Biomarker
- Improved Apgar Score at 1 Minute
- Improved Arginine to Asymmetric Dimethylarginine Ratio
- Improved Birth Weight
- Improved Endothelium-Dependent Vasodilation
- Improved Fetoplacental Circulation
- Improved Fluid Balance
- Improved Maternal Health
- Improved Perinatal Safety
- Improved Physiological Status in Offspring
- Improved Pregnancy Outcome
- Improved Safety in Pregnant Women
- Improved Survival Free from Neurodisability
- Improved Uterine Artery Doppler Parameter
- Increased 6-keto Prostaglandin F1a Concentration
- Increased Blood Pressure
- Increased CSF3 Output in Placental Trophoblast Cells
- Increased Cardiac Output
- Increased Circulating Nitric Oxide Level
- Increased Endothelial Progenitor Cell Count
- Increased Folate Content
- Increased L-Arginine to ADMA Ratio
- Increased L-arginine Level
- Increased Leg Circumference
- Increased Maternal Weight Gain During Pregnancy
- Increased Neonatal Death
- Increased Nitrate Level
- Increased PGDH Expression in Female Placentae
- Increased Plasma Serotonin Levels
- Increased Plasminogen Activator Inhibitor-1 Level
- Increased Systolic Blood Pressure
- Increased Total Body Water
- Increased VEGF Level
- Increased VEGF mRNA Level
- Influence on Infant Weight
- Modified Fetal Brain Metabolism
- Modulated Maternal Immune Response
- No Improvement in Adverse Pregnancy Outcomes
- No Significant Change in Blood Pressure
- Normal Pregnancy Outcomes
- Partially Reduced PTGS2 Levels in Male Placentas
- Prolonged Gestation
- Reduced Acute Kidney Injury Severity
- Reduced Arginine Level
- Reduced Birth Weight
- Reduced Choline Level
- Reduced Eclampsia
- Reduced Eclamptic Seizure Incidence
- Reduced Edema
- Reduced Fetal Blood-Brain Barrier Dysfunction
- Reduced Fetal Complication
- Reduced Fetal Loss
- Reduced Folic Acid Level
- Reduced Gestational Age at Delivery
- Reduced Gestational Hypertension
- Reduced HIF-1α Level
- Reduced Intrauterine Fetal Demise
- Reduced Intrauterine Growth Restriction
- Reduced Maternal Complication
- Reduced Maternal Death
- Reduced Maternal Death or Severe Morbidity
- Reduced Maternal Mortality
- Reduced Maternal and Neonatal Composite Outcome
- Reduced Maternal-Fetal Complications
- Reduced Matrix Metalloproteinase-9 Level
- Reduced NICU Requirement
- Reduced Neonatal Complication
- Reduced Neonatal Death
- Reduced Neonatal Risk
- Reduced Nifedipine Dose
- Reduced Perinatal Loss
- Reduced Perinatal Mortality
- Reduced Postpartum Hemorrhage Rate
- Reduced Pre-eclampsia or Pregnancy Loss
- Reduced Preeclampsia Risk
- Reduced Pregnancy Disorder Risk
- Reduced Preterm Birth
- Reduced Preterm Birth Rate
- Reduced Preterm Births
- Reduced Preterm Delivery
- Reduced Proteinuria
- Reduced Proteinuria Level
- Reduced Rate of Preterm Births Under 34 Weeks
- Reduced Respiratory Distress Syndrome
- Reduced Risk of Infant Health Problems
- Reduced Risk of Preeclampsia
- Reduced Risk of Pregnancy Complications
- Reduced Risk of Severe Pre-eclampsia
- Reduced Risk of Small-for-Gestational-Age Birth
- Reduced Stillbirth
- Reduced Stillbirth or Fetal Death
- Reduced Total Vascular Conductance
- Reduced Urinary Nitrite Level
- Reduced Urinary Protein Level
- Reduced Vascular Endothelial Growth Factor
- Reduced Vascular Endothelial Growth Factor Level
- Reversed Endothelial Cell Morphological Abnormality
- Safety During Pregnancy
- Shortened Labor Duration
- Successful Pregnancy Outcome
- Tolerability of Probiotics in Pregnancy